Nutex Health Inc. (NUTX) stock
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3072% below fair value
$174.51+4.81 (+2.83%)
Close on Nov 17, 2026Market cap $1.20BP/E 6.9Yield –
Nutex Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Nutex Health's operating income for the twelve months ending Jun 30, 2026 was $364.27M, up 52.9% year over year. For fiscal 2025 it was $275.63M, up 110.9% from the year before. The highest annual figure on record is $275.63M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $275.63M | +110.9% |
| FY2024 | Dec 31, 2024 | $130.70M | – |
| FY2023 | Dec 31, 2023 | -$31.77M | – |
| FY2022 | Dec 31, 2022 | -$406.60M | -338.8% |
| FY2021 | Dec 31, 2021 | $170.26M | +11.2% |
| FY2020 | Dec 31, 2020 | $153.17M | – |
| FY2019 | Dec 31, 2019 | -$6.90M | – |
| FY2018 | Dec 31, 2018 | -$840.40K | – |
| FY2017 | Dec 31, 2017 | -$5.69M | – |
| FY2016 | Dec 31, 2016 | -$448.60K | – |
| FY2015 | Dec 31, 2015 | -$532.99K | – |
| FY2014 | Dec 31, 2014 | -$723.43K | – |
| FY2013 | Dec 31, 2013 | -$727.38K | – |
| FY2012 | Dec 31, 2012 | -$1.57M | – |
| FY2011 | Dec 31, 2011 | -$844.58K | – |
| FY2010 | Dec 31, 2010 | -$1.35M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $121.72M | +261.4% |
| Q1 FY2026 | Mar 31, 2026 | $81.27M | +0.7% |
| Q4 FY2025 | Dec 31, 2025 | $30.92M | -72.9% |
| Q3 FY2025 | Sep 30, 2025 | $130.37M | +1249.1% |
| Q2 FY2025 | Jun 30, 2025 | $33.68M | +535.6% |
| Q1 FY2025 | Mar 31, 2025 | $80.66M | +5462.8% |
| Q4 FY2024 | Dec 31, 2024 | $114.21M | – |
| Q3 FY2024 | Sep 30, 2024 | $9.66M | – |
| Q2 FY2024 | Jun 30, 2024 | $5.30M | – |
| Q1 FY2024 | Mar 31, 2024 | $1.45M | – |
| Q4 FY2023 | Dec 31, 2023 | -$26.14M | – |
| Q3 FY2023 | Sep 30, 2023 | -$821.23K | – |
| Q2 FY2023 | Jun 30, 2023 | -$362.54K | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.45M | -115.2% |
| Q4 FY2022 | Dec 31, 2022 | -$5.78M | -137.2% |
| Q3 FY2022 | Sep 30, 2022 | -$428.68M | -675.7% |
| Q2 FY2022 | Jun 30, 2022 | -$1.38M | -105.0% |
| Q1 FY2022 | Mar 31, 2022 | $29.24M | – |
| Q4 FY2021 | Dec 31, 2021 | $15.54M | -89.8% |
| Q3 FY2021 | Sep 30, 2021 | $74.46M | +4092.7% |
| Q2 FY2021 | Jun 30, 2021 | $27.60M | +4176.1% |
| Q1 FY2021 | Mar 31, 2021 | -$4.15M | – |
| Q4 FY2020 | Dec 31, 2020 | $151.69M | – |
| Q3 FY2020 | Sep 30, 2020 | $1.78M | – |
| Q2 FY2020 | Jun 30, 2020 | $645.56K | – |
| Q1 FY2020 | Mar 31, 2020 | -$939.92K | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.58M | -937.3% |
| Q3 FY2019 | Sep 30, 2019 | -$906.13K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.49M | – |
| Q1 FY2019 | Mar 31, 2019 | -$925.91K | – |
| Q4 FY2018 | Dec 31, 2018 | $427.59K | – |
| Q3 FY2018 | Sep 30, 2018 | -$367.01K | – |
| Q2 FY2018 | Jun 30, 2018 | -$489.01K | – |
| Q1 FY2018 | Mar 31, 2018 | -$411.97K | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.25M | – |
| Q1 FY2017 | Mar 31, 2017 | -$163.21K | – |
| Q4 FY2016 | Dec 31, 2016 | -$146.45K | – |
| Q3 FY2016 | Sep 30, 2016 | -$75.70K | – |
| Q2 FY2016 | Jun 30, 2016 | -$64.51K | – |
See a number that looks wrong?